XRAY — DENTSPLY SIRONA Inc. stock price, charts and financials

QT51DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.78
-0.34-2.85%
OverviewShort InterestFilings
XRAYQT51DENTSPLY SIRONA Inc.·NASDAQ
11.78-2.85%
News
Down 2.8% — DENTSPLY SIRONA Q2 Earnings Call Highlights (marketbeat.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
ATRC+0.92%$41.77PLSE-0.80%$42.07LMAT-1.08%$80.57BLFS-0.63%$34.44KMTS+7.19%$28.30AZTA+2.48%$32.84NVST-0.09%$28.13ICUI+0.26%$185.04
Snapshot
Index-P/E-EPS (ttm)-3.15Insider Own3.11%Shs Outstand200.33MPerf Week-9.35%
Market Cap2.43BForward P/E7.80EPS next Y1.55Insider Trans2.19%Shs Float199.22MPerf Month1.93%
Enterprise Value4.50BPEG-EPS next Q-Inst Own-Short Float15.03%Perf Quarter10.58%
Income-547.75MP/S0.67EPS this Y145.06%Inst Trans-Short Ratio5.40Perf Half Y-3.27%
Sales3.64BP/B1.79EPS next Y9.44%ROA-10.49%Short Interest29.94MPerf YTD6.04%
Book/sh-P/C6.74EPS next 5Y6.51%ROE-39.81%52W High14.44 -18.44%Perf Year-11.40%
Cash/sh-P/FCF18.53EPS past 3/5Y-ROIC10.03%52W Low9.13 28.94%Perf 3Y-70.20%
Dividend Est.0.64 (5.44%)EV/EBITDA26.17Sales past 3/5Y-2.10% 1.96%Gross Margin49.52%Volatility5.78% 5.09%Perf 5Y-81.65%
Dividend TTM0.32 (2.72%)EV/Sales1.24EPS Y/Y TTM29.69%Oper. Margin11.69%ATR (14)0.70Perf 10Y-80.79%
Dividend Ex-DateDec 26, 2025Quick Ratio1.07Sales Y/Y TTM-2.95%Profit Margin-14.99%RSI (14)43.45Recom2.65
Dividend Gr. 3/5Y8.58% 9.86%Current Ratio1.63EPS Q/Q-37.21%SMA20-9.59%Beta0.83Target Price13.25
Payout-23.44%Debt/Eq1.71Sales Q/Q0.11%SMA503.16%Rel Volume1.48Prev Close12.12
Employees14,000LT Debt/Eq1.57EarningsOct 29SMA2002.52%Avg Volume5.80MPrice11.78
IPO DateAug 12, 1987Option/ShortYes / YesEPS/Sales Surpr.-2.70% 4.54%Net Debt/EBITDA12.05Volume8,569,129Change-2.85%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-07-26ReiteratedBMO Capital$12 → $13
Jul-29-26ReiteratedPiper SandlerNeutral$32 → $14
Jul-08-26InitiatedBMO CapitalMarket Perform$12
Jun-04-26ReiteratedBarclaysUnderweight$12 → $9.00
May-07-26ReiteratedUBSBuy$16 → $17
Feb-19-26UpgradeB of A SecuritiesNeutral → Buy
Feb-03-26ReiteratedUBSBuy$23 → $16
Jan-20-26ReiteratedMizuhoNeutral$13 → $14
Dec-16-25ReiteratedRobert W. Baird$14 → $12
Dec-08-25InitiatedBarclaysUnderweight$12
Latest News
Aug-07-26
Aug-07-2605:06PM
DENTSPLY SIRONA Q2 Earnings Call Highlightsmarketbeat.com
03:41PM
XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Saleszacks.com
10:31AM
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earningszacks.com
Aug-06-26
Aug-06-2608:54PM
DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcriptseekingalpha.com
06:40PM
Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimateszacks.com
04:01PM
Dentsply Sirona Reports Second Quarter 2026 Resultsglobenewswire.com
03:05AM
Arkadios Wealth Advisors Purchases New Stake in DENTSPLY SIRONA Inc. $XRAYdefenseworld.net
Aug-04-26
Aug-04-2601:26PM
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?zacks.com
03:59AM
Dimensional Fund Advisors LP Raises Stake in DENTSPLY SIRONA Inc. $XRAYdefenseworld.net
Jul-29-26
Jul-29-2601:17PM
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14Benzinga
09:13AM
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?prnewswire.com
Jul-28-26
Jul-28-2608:30AM
Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationshipglobenewswire.com
Jul-24-26
Jul-24-2606:57PM
3 Reasons to Sell XRAY and 1 Stock to Buy InsteadYahoo
Jul-21-26
Jul-21-2604:15PM
Dentsply Sirona to Host Second Quarter Conference Call on August 6thglobenewswire.com
Jul-20-26
Jul-20-2601:52AM
Ariel Focus Fund Q2 2026 Portfolio ActivitySeekingAlpha
Company

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue3,6433,6803,793——————
Cost of Goods Sold Incl. D&A1,8391,8401,835——————
Gross Profit1,8041,8401,958——————
Selling, General and Administrative Excl. Other1,4581,4381,605——————
Research and Development166150165——————
Other Operating Expense-24601,067——————
Operating Income426252-879——————
Interest Expense918869——————
Unusual Expense
—————————
Non-Operating Income (Expense)-682-65012——————
Net Income Before Taxes-347-486-936——————
Income Taxes200112-26——————
Consolidated Net Income-546-598-910——————
Net Income From Continuing Operations-547-598-910——————
Net Income-546-598-910——————
EPS (Recurring)-2.74-3.00-4.48——————
EPS (Basic, Before Extraordinaries)-2.74-3.00-4.48——————
EPS (Diluted)-2.74-3.00-4.48——————
EBITDA172-46-518——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio
—————————
Price To Sales Ratio0.650.621.02——————
Gross Margin49.5250.0051.62——————
Operating Margin11.696.85-23.17——————
Net Margin-14.99-16.25-23.99——————
Shares Outstanding200199203——————
Market Capitalization2,3552,2753,853——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$17.93$15.59$13.25$10.90$8.56● Close Price0.00M0.26M0.51M0.77M1.02MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
MAZELSKY JONATHAN JAYDirectorJun 12 '26Buy10.1410,000101,40061,669Jun 18
HOSEIN CLYDEDirectorJun 15 '26Buy9.986,50064,90270,575Jun 16
Gladden Brian TDirectorJun 15 '26Buy10.029,985100,00061,849Jun 15
MCKEON BRIAN PDirectorJun 12 '26Buy10.1210,000101,20010,000Jun 15
HOLDEN BETSY DDirectorJun 11 '26Buy9.8810,08699,69287,528Jun 15
Barber Michael JDirectorJun 11 '26Buy9.8815,175150,00555,943Jun 15
LUCIER GREGORY TDirectorMar 09 '26Buy12.4515,000186,67565,000Mar 09
Forbes James DDirectorMar 09 '26Buy12.485,00062,40010,000Mar 09
LUCIER GREGORY TDirectorMar 03 '26Buy14.0322,445314,85850,000Mar 03
Forbes James DDirectorMar 03 '26Buy13.475,00067,3455,000Mar 03
LUCIER GREGORY TDirectorMar 02 '26Buy14.2427,555392,52127,555Mar 03
LUCIER GREGORY TDirectorDec 08 '25Sale11.1482,200915,7080Dec 10
VARON LESLIE FDirectorNov 24 '25Buy10.719,33799,99957,343Nov 25
LUCIER GREGORY TDirectorMar 03 '25Buy16.5115,142249,99481,971Mar 03
LUCIER GREGORY TDirectorNov 18 '24Buy18.3710,000183,70071,730Jan 29
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.